GemVax & Kael
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety, Tolerability and PK Characteristics of GV1001 in Healthy Subjects (NCT06625710) | GemVax & Kael | 2024-10-08 |
| Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011 (NCT06235775) | GemVax & Kael | 2023-12-12 |
| Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH) (NCT04032067) | GemVax & Kael | 2019-10-30 |
| Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients (NCT03184467) | GemVax & Kael | 2017-09-05 |
Track GemVax & Kael automatically
Every clearance here is in the API, with alerts when new ones post.